menu
    • menu

    Company profile for Curi Bio

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Curi Bio is accelerating the discovery of the next generation of medicines by integrating human cells, systems, and data.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Curi BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3000 Western Avenue, Suite 400 Seattle, WA 98121
    Telephone
    Telephone
    +1 (800) 913-4403
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.curibio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/curibio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/curi_bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Curi Bio Establishes Asia-Pacific Hub To Enhance Support
    Curi Bio Establishes Asia-Pacific Hub To Enhance Support

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112815002/en/Curi-Bio-Launches-Asia-Pacific-Hub-Delivering-Greater-Support-to-its-Growing-APAC-Business

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Curi Bio Secures $10M Series B For Drug Discovery Platforms
    Curi Bio Secures $10M Series B For Drug Discovery Platforms

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202219723/en/Curi-Bio-Secures-%2410M-Series-B-to-Scale-Human-Relevant-Preclinical-Platforms-and-Advanced-Data-Analysis-for-Drug-Discovery

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    Curi Bio and Cook MyoSite Announce Strategic Partnership
    Curi Bio and Cook MyoSite Announce Strategic Partnership

    30 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250430505035/en/Curi-Bio-and-Cook-MyoSite-Announce-Strategic-Partnership

    BUSINESSWIRE
    30 Apr 2025
    Share Share
    Curi Bio Opens New Global Headquarters in Seattle
    Curi Bio Opens New Global Headquarters in Seattle

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408969541/en/Curi-Bio-Celebrates-Grand-Opening-of-New-Global-Headquarters-in-Seattle

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    Curi Bio Unlocks Cardiac Insights with Novoheart Integration
    Curi Bio Unlocks Cardiac Insights with Novoheart Integration

    19 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241219778960/en

    BUSINESSWIRE
    19 Dec 2024
    Share Share
    Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner
    Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner

    22 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241122635899/en

    BUSINESSWIRE
    22 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search